Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pujade-Lauraine

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Cancer of the ovary. New therapeutic approaches]E Pujade-Lauraine
Bulletin Du Cancer|February 24, 2001
[10 years of carboplatin]E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to approach patients in relapseE Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
New treatments in ovarian cancerE Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Update of randomized trials in recurrent diseaseE Pujade-Lauraine, J Alexandre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Recurrent ovarian cancerE Pujade-Lauraine, P Combe
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1990
[Isolated splenic metastases of cancer of the ovary]J P Cleophax, E Pujade-Lauraine
Bulletin Du Cancer|April 1, 1995
[Autocrine stimulation of cell proliferation in colonic carcinoma: a biological curiosity or a new therapeutic target?]J M Rodier, E Pujade-Lauraine
Critical Reviews in Oncology/Hematology|May 12, 2012
Angiogenesis: a promising therapeutic target for ovarian cancerA Bamias, S Pignata, E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2014
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?G Emile, E Pujade-Lauraine, J Alexandre
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|January 22, 1994
[Cancer of the ovary. New therapeutic approaches]E Pujade-Lauraine
Bulletin Du Cancer|February 24, 2001
[10 years of carboplatin]E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to approach patients in relapseE Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
New treatments in ovarian cancerE Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Update of randomized trials in recurrent diseaseE Pujade-Lauraine, J Alexandre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Recurrent ovarian cancerE Pujade-Lauraine, P Combe
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1990
[Isolated splenic metastases of cancer of the ovary]J P Cleophax, E Pujade-Lauraine
Bulletin Du Cancer|April 1, 1995
[Autocrine stimulation of cell proliferation in colonic carcinoma: a biological curiosity or a new therapeutic target?]J M Rodier, E Pujade-Lauraine
Critical Reviews in Oncology/Hematology|May 12, 2012
Angiogenesis: a promising therapeutic target for ovarian cancerA Bamias, S Pignata, E Pujade-Lauraine
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2014
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?G Emile, E Pujade-Lauraine, J Alexandre
Pageof 12